Literature DB >> 12417590

Interleukin-23 promotes a distinct CD4 T cell activation state characterized by the production of interleukin-17.

Sudeepta Aggarwal1, Nico Ghilardi, Ming-Hong Xie, Frederic J de Sauvage, Austin L Gurney.   

Abstract

Interleukin (IL)-17 is a pro-inflammatory cytokine that is produced by activated T cells. Despite increasing evidence that high levels of IL-17 are associated with several chronic inflammatory diseases including rheumatoid arthritis, psoriasis, and multiple sclerosis, the regulation of its expression is not well characterized. We observe that IL-17 production is increased in response to the recently described cytokine IL-23. We present evidence that murine IL-23, which is produced by activated dendritic cells, acts on memory T cells, resulting in elevated IL-17 secretion. IL-23 also induced expression of the related cytokine IL-17F. IL-23 is a heterodimeric cytokine and shares a subunit, p40, with IL-12. In contrast to IL-23, IL-12 had only marginal effects on IL-17 production. These data suggest that during a secondary immune response, IL-23 can promote an activation state with features distinct from the well characterized Th1 and Th2 profiles.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12417590     DOI: 10.1074/jbc.M207577200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  626 in total

1.  Cutting edge: roles of Toll-like receptor 4 and IL-23 in IL-17 expression in response to Klebsiella pneumoniae infection.

Authors:  Kyle I Happel; Mingquan Zheng; Erana Young; Lee J Quinton; Euan Lockhart; Alistair J Ramsay; Judd E Shellito; Jill R Schurr; Gregory J Bagby; Steve Nelson; Jay K Kolls
Journal:  J Immunol       Date:  2003-05-01       Impact factor: 5.422

Review 2.  Emerging roles of T helper subsets in the pathogenesis of asthma.

Authors:  Douglas M Durrant; Dennis W Metzger
Journal:  Immunol Invest       Date:  2010       Impact factor: 3.657

3.  A novel immunoregulatory function for IL-23: Inhibition of IL-12-dependent IFN-γ production.

Authors:  Amy N Sieve; Karen D Meeks; Suheung Lee; Rance E Berg
Journal:  Eur J Immunol       Date:  2010-08       Impact factor: 5.532

4.  The tick saliva immunosuppressor, Salp15, contributes to Th17-induced pathology during Experimental Autoimmune Encephalomyelitis.

Authors:  Ignacio J Juncadella; Tonya C Bates; Reem Suleiman; Andrea Monteagudo-Mera; Chris M Olson; Nicolás Navasa; Elias R Olivera; Barbara A Osborne; Juan Anguita
Journal:  Biochem Biophys Res Commun       Date:  2010-11-05       Impact factor: 3.575

Review 5.  Interleukin-23 and T helper 17-type responses in intestinal inflammation: from cytokines to T-cell plasticity.

Authors:  Peter J Morrison; Sarah J Ballantyne; Marika C Kullberg
Journal:  Immunology       Date:  2011-06-02       Impact factor: 7.397

Review 6.  A tale of two cytokines: IL-17 and IL-22 in asthma and infection.

Authors:  Michelle L Manni; Keven M Robinson; John F Alcorn
Journal:  Expert Rev Respir Med       Date:  2013-12-10       Impact factor: 3.772

7.  Chlamydophila pneumoniae re-infection triggers the production of IL-17A and IL-17E, important regulators of airway inflammation.

Authors:  Tímea Mosolygó; József Korcsik; Emese Petra Balogh; Ildikó Faludi; Dezső P Virók; Valéria Endrész; Katalin Burián
Journal:  Inflamm Res       Date:  2013-02-06       Impact factor: 4.575

8.  IL-17 secreted by tumor reactive T cells induces IL-8 release by human renal cancer cells.

Authors:  Takashi Inozume; Ken-ichi Hanada; Qiong J Wang; James C Yang
Journal:  J Immunother       Date:  2009 Feb-Mar       Impact factor: 4.456

9.  IL-17 promotes progression of cutaneous leishmaniasis in susceptible mice.

Authors:  Susanna Lopez Kostka; Stephanie Dinges; Klaus Griewank; Yoichiro Iwakura; Mark C Udey; Esther von Stebut
Journal:  J Immunol       Date:  2009-03-01       Impact factor: 5.422

10.  Transgenic inhibition of astroglial NF-kappa B improves functional outcome in experimental autoimmune encephalomyelitis by suppressing chronic central nervous system inflammation.

Authors:  Roberta Brambilla; Trikaldarshi Persaud; Xianchen Hu; Shaffiat Karmally; Valery I Shestopalov; Galina Dvoriantchikova; Dmitry Ivanov; Lubov Nathanson; Scott R Barnum; John R Bethea
Journal:  J Immunol       Date:  2009-03-01       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.